Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brit Mollenhauer

Showing results (131-140 of 304) with videos related to

Pageof 31
Sort By:
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter CohortInger van Steenoven, Dag Aarsland, Daniel Weintraub, et al.
NPJ Parkinson'S Disease|November 20, 2025
Synphilin-1 modulates alpha-synuclein assembly, release and uptakeDiana F Lázaro, Triana Amen, Ellen Gerhardt, et al.
Journal of Sleep Research|April 26, 2022
Rapid eye movement sleep behaviour disorder: Past, present, and futureBirgit Högl, Isabelle Arnulf, Melanie Bergmann, et al.
The Journal of Physical Chemistry. B|April 24, 2026
An Immuno-Infrared Sensor Detects Preclinical Alzheimer's and Parkinson's Disease by Protein MisfoldingGrischa Gerwert, Marvin Mann, Lennart Langenhoff, et al.
Neurology|February 6, 2025
α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson DiseaseDavid G Coughlin, Ben Shifflett, Carly M Farris, et al.
Nature Communications|June 3, 2020
A nanobody-based fluorescent reporter reveals human α-synuclein in the cell cytosolChristoph Gerdes, Natalia Waal, Thomas Offner, et al.
Journal of Parkinson'S Disease|August 28, 2019
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change MeasuresLana M Chahine, Andrew Siderowf, Janel Barnes, et al.
Translational Neurodegeneration|May 8, 2020
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriersNour K Majbour, Jan O Aasly, Eldbjørg Hustad, et al.
Neurology|September 3, 2013
Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohortBrit Mollenhauer, Ellen Trautmann, Friederike Sixel-Döring, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 13, 2023
Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) CohortLuis Concha-Marambio, Sandrina Weber, Carly M Farris, et al.
Pageof 31

Showing results (131-140 of 304) with videos related to

Sort By:
Pageof 31
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter CohortInger van Steenoven, Dag Aarsland, Daniel Weintraub, et al.
NPJ Parkinson'S Disease|November 20, 2025
Synphilin-1 modulates alpha-synuclein assembly, release and uptakeDiana F Lázaro, Triana Amen, Ellen Gerhardt, et al.
Journal of Sleep Research|April 26, 2022
Rapid eye movement sleep behaviour disorder: Past, present, and futureBirgit Högl, Isabelle Arnulf, Melanie Bergmann, et al.
The Journal of Physical Chemistry. B|April 24, 2026
An Immuno-Infrared Sensor Detects Preclinical Alzheimer's and Parkinson's Disease by Protein MisfoldingGrischa Gerwert, Marvin Mann, Lennart Langenhoff, et al.
Neurology|February 6, 2025
α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson DiseaseDavid G Coughlin, Ben Shifflett, Carly M Farris, et al.
Nature Communications|June 3, 2020
A nanobody-based fluorescent reporter reveals human α-synuclein in the cell cytosolChristoph Gerdes, Natalia Waal, Thomas Offner, et al.
Journal of Parkinson'S Disease|August 28, 2019
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change MeasuresLana M Chahine, Andrew Siderowf, Janel Barnes, et al.
Translational Neurodegeneration|May 8, 2020
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriersNour K Majbour, Jan O Aasly, Eldbjørg Hustad, et al.
Neurology|September 3, 2013
Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohortBrit Mollenhauer, Ellen Trautmann, Friederike Sixel-Döring, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 13, 2023
Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) CohortLuis Concha-Marambio, Sandrina Weber, Carly M Farris, et al.
Pageof 31